Ledger.Open graph →
SEC Form D · filed October 8, 2019

CONSTELLATION PHARMACEUTICALS INC

Offering
$65.0M
Sold
$65.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
CAMBRIDGE, MA
Type

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (30)

Jigar Raythatha · Cambridge, MAExec · DirectorRobert A. Tepper · Cambridge, MADirectorMark A. Goldsmith · Cambridge, MADirectorEmma E. Reeve · Cambridge, MAExecJames E. Audia · Cambridge, MADirectorAnthony A. Evnin · Cambridge, MADirectorPatrick G. Trojer · Cambridge, MAExecWayne S. Kirk · Vancouver, British Columbia, CanadaDirectorSeth Rodsky · Brooklyn, NYExecJonathan C. Trousdale · Dania Beach, FLDirectorMark S. Fields · Vancouver, British Columbia, CanadaDirectorJayendra E. Das · BOSTON, MADirectorKevin Chen · Brooklyn, NYExec · DirectorElizabeth G. Trehu · Cambridge, MADirectorSteven G. Hoerter · Cambridge, MADirectorScott G. Braunstein · Cambridge, MADirectorAdrian G. Senderowicz · Cambridge, MAExecKaren G. Valentine · Cambridge, MAExecJoseph Kinsella · BOSTON, MADirectorAriel E. Tseitlin · BOSTON, MADirectorRobert C. Mcguire · PITTSBURGH, PADirectorMichael T. Puckett · New Orleans, LADirectorSteven Mintz · Vancouver, British Columbia, CanadaExec · DirectorJesse Kaplan · Vancouver, British Columbia, CanadaExecPatrick G. Trojer · Cambridge, MAExecElizabeth G. Trehu · Cambridge, MADirectorSteven G. Hoerter · Cambridge, MADirectorScott G. Braunstein · Boston, MADirectorAdrian G. Senderowicz · Cambridge, MAExecKaren G. Valentine · Cambridge, MAExec

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗